AstraZeneca held talks with Bristol Myers Squibb on $400 billion megadeal, source says

By Sabrina Valle and Michael Erman Aug 2 (Reuters) – AstraZeneca Plc and Bristol Myers Squibb held preliminary discussions about a possible combination that would create one of the world's biggest

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)